PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Eotaxin 2,457 Target Target 464.1 19 1 0.00 -0.97 0.05 0.66
Acute Promyelocytic Leukemia 4,780 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.65
Prostate Cancer 71,064 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.58
Renal Failure 73,993 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.58
Diabetes 332,602 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.55
Carcinoma 433,099 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.54
Cancer 1,053,491 Disease Target 464.1 19 2 0.00 -0.95 0.11 0.54
4-Mercaptopyridine 96 Drug Drug 4-Mercaptobenzoic Acid 70 2 0.02 -0.98 0.03 0.79
Dehydration 21,928 Disease Drug 4-Mercaptobenzoic Acid 70 1 0.00 -0.99 0.01 0.59
Hepatitis B 57,815 Disease Drug 4-Mercaptobenzoic Acid 70 2 0.00 -0.99 0.03 0.58
Cancer 1,053,491 Disease Drug 4-Mercaptobenzoic Acid 70 4 0.00 -0.97 0.06 0.53
Carcinoma 433,099 Disease Drug 4-Mercaptobenzoic Acid 70 1 0.00 -0.99 0.01 0.52
Graft Versus Host Disease 15,741 Disease Target 4-1BB Receptor 20 2 0.00 -0.95 0.10 0.63
CD4 112,219 Target Target 4-1BB Receptor 20 9 0.01 -0.74 0.45 0.62
Carcinoma 433,099 Disease Target 4-1BB Receptor 20 3 0.00 -0.92 0.15 0.56
Cancer 1,053,491 Disease Target 4-1BB Receptor 20 5 0.00 -0.87 0.25 0.56
4-1BB Receptor 20 Target Target 4-1BB Ligand 135 9 0.17 -0.72 0.45 0.85
BAFF 1,240 Target Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.65
CD1A 2,739 Target Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.63
CD4 112,219 Target Target 4-1BB Ligand 135 36 0.01 -0.86 0.27 0.63
CD14 9,941 Target Target 4-1BB Ligand 135 3 0.00 -0.99 0.02 0.63
Graft Versus Host Disease 15,741 Disease Target 4-1BB Ligand 135 2 0.00 -0.99 0.01 0.60
Conjunctivitis 8,825 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.60
CEA 17,022 Target Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.58
Cervical Cancer 28,286 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.57
Colon Cancer 30,064 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.57
Carcinoma 433,099 Disease Target 4-1BB Ligand 135 14 0.00 -0.95 0.10 0.57
Cancer 1,053,491 Disease Target 4-1BB Ligand 135 27 0.00 -0.89 0.20 0.56
Infection 766,637 Disease Target 4-1BB Ligand 135 11 0.00 -0.96 0.08 0.55
Obesity 138,233 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.53
Diabetes 332,602 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.52
Epidermal Growth Factor Receptor 24,772 Target Target 3-Phosphoinositide-Dependent Protein Kinase 1 230 3 0.00 -0.99 0.01 0.59
Non Small Cell Lung Cancer 28,563 Disease Target 3-Phosphoinositide-Dependent Protein Kinase 1 230 2 0.00 -1.00 0.01 0.58
Colon Cancer 30,064 Disease Target 3-Phosphoinositide-Dependent Protein Kinase 1 230 2 0.00 -1.00 0.01 0.57
Lung Cancer 91,416 Disease Target 3-Phosphoinositide-Dependent Protein Kinase 1 230 4 0.00 -0.99 0.02 0.56
Diabetes 332,602 Disease Target 3-Phosphoinositide-Dependent Protein Kinase 1 230 9 0.00 -0.98 0.04 0.55
CD4 112,219 Target Target 3-Phosphoinositide-Dependent Protein Kinase 1 230 1 0.00 -1.00 0.00 0.53
Steroid 5-Alpha-Reductase 293 Target Target 11-Beta-Hydroxylase 721 4 0.01 -0.99 0.01 0.71
Lanosterol 14 Alpha-Demethylase 101 Target Target 11-Beta-Hydroxylase 721 1 0.00 -0.99 0.01 0.68
Gynecomastia 2,594 Disease Target 11-Beta-Hydroxylase 721 7 0.01 -0.99 0.01 0.67
Renin 43,456 Target Target 11-Beta-Hydroxylase 721 55 0.01 -0.96 0.08 0.64
Glucocorticoid Receptor 10,306 Target Target 11-Beta-Hydroxylase 721 7 0.00 -0.99 0.01 0.62
Cholesterol 182,390 Disease Target 11-Beta-Hydroxylase 721 98 0.01 -0.93 0.14 0.61
Acne 11,364 Disease Target 11-Beta-Hydroxylase 721 5 0.00 -1.00 0.01 0.61
Hyperprolactinemia 4,112 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.59
Hyperbilirubinemia 5,757 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.58
Calmodulin 25,240 Target Target 11-Beta-Hydroxylase 721 3 0.00 -1.00 0.00 0.57
Sedation 27,984 Disease Target 11-Beta-Hydroxylase 721 3 0.00 -1.00 0.00 0.56
Platelet Activating Factor 9,915 Target Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.56
Hypoglycemia 20,698 Disease Target 11-Beta-Hydroxylase 721 2 0.00 -1.00 0.00 0.56